Adalimumab for Crohn's disease in clinic
β
Jason M. Swoger; Edward V. Loftus Jr.; William J. Tremaine; William A. Faubion;
π
Article
π
2010
π
John Wiley and Sons
π
English
β 132 KB
π 1 views
## Background: We sought to assess the effectiveness and safety of adalimumab for the treatment of Crohn's disease (CD) in clinical practice. Methods: Demographic, clinical, and treatment data were abstracted from the medical record. The primary outcome was clinical response to induction therapy